Atrial fibrillation causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 38: Line 38:
{|style="width:80%; height:100px" border="1"
{|style="width:80%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[atrial infarction|Atrial ischemia]], [[atrial myxoma]], [[atrial septal defect]] [[cardiac tumors]], [[cardiomyopathy]], [[congenital heart disease]], [[congestive heart failure]], [[constrictive  pericarditis]], [[coronary artery bypass graft  surgery]], [[coronary artery disease]], [[endocarditis]], [[familial atrial fibrillation]], [[hypertensive heart disease]], [[hypertrophic  cardiomyopathy]], [[Lutembacher syndrome]], [[mitral regurgitation]], [[mitral stenosis]], [[myocardial infarction]], [[myocarditis]], [[pericarditis]], [[peripartum  cardiomyopathy]], [[pulmonary embolism]], [[pulmonary hypertension]], [[tricuspid regurgitation]], [[tricuspid stenosis]], [[unstable angina]], [[uremic pericarditis]], [[valvular heart disease]]
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[atrial infarction|Atrial ischemia]], [[atrial myxoma]], [[atrial septal defect]] [[cardiac tumors]], [[cardiomyopathy]], [[congenital heart disease]], [[congestive heart failure]], [[constrictive  pericarditis]], [[coronary artery bypass graft  surgery]], [[coronary artery disease]], [[dilated cardiomyopathy]], [[endocarditis]], [[familial atrial fibrillation]], [[hypertensive heart disease]], [[hypertrophic  cardiomyopathy]], [[ischemic heart disease]], [[Lutembacher syndrome]], [[mitral regurgitation]], [[mitral stenosis]], [[myocardial infarction]], [[myocarditis]], [[pericarditis]], [[peripartum  cardiomyopathy]], [[pulmonary embolism]], [[pulmonary hypertension]], [[systemic hypertension]], [[tricuspid regurgitation]], [[tricuspid stenosis]], [[unstable angina]], [[uremic pericarditis]], [[valvular heart disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 54: Line 54:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Conivaptan]], [[caspofungin acetate]], [[cyclophosphamide]], [[etravirine]], [[febuxostat]], [[felbamate]], [[granisetron]], [[guanidine]], [[ibrutinib]], [[idarubicin hydrochloride]], [[ioxilan]], [[lacosamide]], [[metipranolol]], [[niacin]], [[oprelvekin]], [[pergolide]], [[porfimer sodium]], [[pramipexole]], [[ropinirole]]
|bgcolor="Beige"| [[Caspofungin acetate]], [[conivaptan]], [[cyclophosphamide]], [[etravirine]], [[febuxostat]], [[felbamate]], [[granisetron]], [[guanidine]], [[ibrutinib]], [[idarubicin hydrochloride]], [[ioxilan]], [[interleukin 2]], [[lacosamide]], [[metipranolol]], [[niacin]], [[oprelvekin]], [[pergolide]], [[porfimer sodium]], [[pramipexole]], [[ropinirole]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 74: Line 74:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Familial atrial fibrillation]], [[hemochromatosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 106: Line 106:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Oncologic'''
| '''Oncologic'''
|bgcolor="Beige"| [[Bronchogenic carcinoma]], [[cardiac tumors]], [[lung cancer]], [[pheochromocytoma]]
|bgcolor="Beige"| [[Atrial myxoma]], [[bronchogenic carcinoma]], [[cardiac tumors]], [[lung cancer]], [[pheochromocytoma]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 130: Line 130:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| [[Collagen  vascular disease]], [[rheumatic heart  disease]], [[sarcoidosis]]
|bgcolor="Beige"| [[Collagen  vascular disease]], [[rheumatic fever]], [[rheumatic heart  disease]], [[sarcoidosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 162: Line 162:
*[[Cardiac tumors]]
*[[Cardiac tumors]]
*[[Cardiomyopathy]]
*[[Cardiomyopathy]]
*[[Caspofungin acetate]]
*[[Channelopaties]]  
*[[Channelopaties]]  
*[[Chronic kidney disease]]
*[[Chronic kidney disease]]
Line 179: Line 180:
*[[Electrolyte disturbance]]
*[[Electrolyte disturbance]]
*[[Endocarditis]]
*[[Endocarditis]]
*[[Etravirine]]
*[[Familial atrial fibrillation ]]
*[[Familial atrial fibrillation ]]
*[[Fatigue]]
*[[Fatigue]]
*[[Febuxostat]]
*[[Felbamate]]
*[[Granisetron]]
*[[Guanidine]]
*[[Hemochromatosis]]
*[[Hemochromatosis]]
*[[Hypertensive heart disease]]<ref name="Krahn-1995">{{Cite journal  | last1 = Krahn | first1 = AD. | last2 = Manfreda | first2 = J. | last3 = Tate | first3 = RB. | last4 = Mathewson | first4 = FA. | last5 = Cuddy | first5 = TE. | title = The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. | journal = Am J Med | volume = 98 | issue = 5 | pages = 476-84 | month = May | year = 1995 | doi = 10.1016/S0002-9343(99)80348-9 | PMID = 7733127 }}</ref><ref name="Kannel-1982">{{Cite journal  | last1 = Kannel | first1 = WB. | last2 = Abbott | first2 = RD. | last3 = Savage | first3 = DD. | last4 = McNamara | first4 = PM. | title = Epidemiologic features of chronic atrial fibrillation: the Framingham study. | journal = N Engl J Med | volume = 306 | issue = 17 | pages = 1018-22 | month = Apr | year = 1982 | doi = 10.1056/NEJM198204293061703 | PMID = 7062992 }}</ref>
*[[Hypertensive heart disease]]<ref name="Krahn-1995">{{Cite journal  | last1 = Krahn | first1 = AD. | last2 = Manfreda | first2 = J. | last3 = Tate | first3 = RB. | last4 = Mathewson | first4 = FA. | last5 = Cuddy | first5 = TE. | title = The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. | journal = Am J Med | volume = 98 | issue = 5 | pages = 476-84 | month = May | year = 1995 | doi = 10.1016/S0002-9343(99)80348-9 | PMID = 7733127 }}</ref><ref name="Kannel-1982">{{Cite journal  | last1 = Kannel | first1 = WB. | last2 = Abbott | first2 = RD. | last3 = Savage | first3 = DD. | last4 = McNamara | first4 = PM. | title = Epidemiologic features of chronic atrial fibrillation: the Framingham study. | journal = N Engl J Med | volume = 306 | issue = 17 | pages = 1018-22 | month = Apr | year = 1982 | doi = 10.1056/NEJM198204293061703 | PMID = 7062992 }}</ref>
Line 188: Line 194:
*[[Hypothyroidism]]
*[[Hypothyroidism]]
*[[Hypoxia]]
*[[Hypoxia]]
*[[Ibrutinib]]
*[[Idarubicin hydrochloride]]
*[[Idarubicin hydrochloride]]
*[[Interleukin 2]]
*[[Ioxilan]]
*[[Ischemic heart disease]]
*[[Lacosamide]]
*[[Left ventricular hypertrophy]]
*[[Left ventricular hypertrophy]]
*[[Lung cancer]]
*[[Lung cancer]]
*[[Lutembacher syndrome]]
*[[Lutembacher syndrome]]
*[[Methamphetamines]]
*[[Methamphetamines]]
*[[Metipranolol]]
*[[Mitral regurgitation]]<ref name="Grigioni-2002">{{Cite journal  | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi =  | PMID = 12103260 }}</ref>
*[[Mitral regurgitation]]<ref name="Grigioni-2002">{{Cite journal  | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi =  | PMID = 12103260 }}</ref>
*[[Mitral stenosis]]
*[[Mitral stenosis]]
Line 207: Line 219:
*[[Pneumonia]]
*[[Pneumonia]]
*[[Porfimer sodium]]
*[[Porfimer sodium]]
*[[Pramipexole]]
*[[Psychological stress]]
*[[Psychological stress]]
*[[Pulmonary embolism]]<ref name="Goldhaber-1999">{{Cite journal  | last1 = Goldhaber | first1 = SZ. | last2 = Visani | first2 = L. | last3 = De Rosa | first3 = M. | title = Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | journal = Lancet | volume = 353 | issue = 9162 | pages = 1386-9 | month = Apr | year = 1999 | doi =  | PMID = 10227218 }}</ref>
*[[Pulmonary embolism]]<ref name="Goldhaber-1999">{{Cite journal  | last1 = Goldhaber | first1 = SZ. | last2 = Visani | first2 = L. | last3 = De Rosa | first3 = M. | title = Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | journal = Lancet | volume = 353 | issue = 9162 | pages = 1386-9 | month = Apr | year = 1999 | doi =  | PMID = 10227218 }}</ref>
*[[Pulmonary hypertension]]
*[[Pulmonary hypertension]]
*[[Renal insufficiency]]
*[[Renal insufficiency]]
*[[Rheumatic fever]]
*[[Rheumatic heart disease]]<ref name="Grigioni-2002">{{Cite journal  | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi =  | PMID = 12103260 }}</ref>
*[[Rheumatic heart disease]]<ref name="Grigioni-2002">{{Cite journal  | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi =  | PMID = 12103260 }}</ref>
*[[Ropinirole]]
*[[Sarcoidosis]]
*[[Sarcoidosis]]
*[[Stroke]]
*[[Stroke]]
*[[Subarachnoid hemorrhage]]
*[[Subarachnoid hemorrhage]]
*[[Surgery]]
*[[Surgery]]
*[[Systemic hypertension]]
*[[Tricuspid regurgitation]]
*[[Tricuspid regurgitation]]
*[[Tricuspid stenosis]]
*[[Tricuspid stenosis]]

Revision as of 15:41, 27 April 2015
Resident
Survival
Guide


Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation causes

CDC on Atrial fibrillation causes

Atrial fibrillation causes in the news

Blogs on Atrial fibrillation causes

Directions to Hospitals Treating Atrial fibrillation causes

Risk calculators and risk factors for Atrial fibrillation causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hilda Mahmoudi M.D., M.P.H.[2]

Overview

Atrial fibrillation can be caused by several organic cardiac diseases, but it has also been reported to have a familial etiology.[1] In developed countries, hypertensive heart disease and coronary heart disease are the two most common causes of atrial fibrillation. However, rheumatic heart disease is associated with a higher incidence of atrial fibrillation in developing countries. Life threatening conditions such as acute coronary syndromes, electrolyte imbalance, hypoxia should be identified and promptly treated.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular Atrial ischemia, atrial myxoma, atrial septal defect cardiac tumors, cardiomyopathy, congenital heart disease, congestive heart failure, constrictive pericarditis, coronary artery bypass graft surgery, coronary artery disease, dilated cardiomyopathy, endocarditis, familial atrial fibrillation, hypertensive heart disease, hypertrophic cardiomyopathy, ischemic heart disease, Lutembacher syndrome, mitral regurgitation, mitral stenosis, myocardial infarction, myocarditis, pericarditis, peripartum cardiomyopathy, pulmonary embolism, pulmonary hypertension, systemic hypertension, tricuspid regurgitation, tricuspid stenosis, unstable angina, uremic pericarditis, valvular heart disease
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Caspofungin acetate, conivaptan, cyclophosphamide, etravirine, febuxostat, felbamate, granisetron, guanidine, ibrutinib, idarubicin hydrochloride, ioxilan, interleukin 2, lacosamide, metipranolol, niacin, oprelvekin, pergolide, porfimer sodium, pramipexole, ropinirole
Ear Nose Throat No underlying causes
Endocrine Diabetes, hyperthyroidism, hypothyroidism
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic Familial atrial fibrillation, hemochromatosis
Hematologic Hemochromatosis
Iatrogenic No underlying causes
Infectious Disease Viral infections
Musculoskeletal/Orthopedic No underlying causes
Neurologic Stroke, subarachnoid hemorrhage
Nutritional/Metabolic Electrolyte disturbance, hemochromatosis
Obstetric/Gynecologic No underlying causes
Oncologic Atrial myxoma, bronchogenic carcinoma, cardiac tumors, lung cancer, pheochromocytoma
Ophthalmologic No underlying causes
Overdose/Toxicity Alcohol, cocaine, methamphetamines
Psychiatric No underlying causes
Pulmonary Bronchogenic carcinoma, chronic obstructive pulmonary disease, hypoxia, lung cancer, obstructive sleep apnea, pneumonia, pulmonary embolism, pulmonary hypertension
Renal/Electrolyte Channelopaties , chronic kidney disease, renal insufficiency
Rheumatology/Immunology/Allergy Collagen vascular disease, rheumatic fever, rheumatic heart disease, sarcoidosis
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Breath spray, caffeine, dehydration, fatigue, hypothermia, psychological stress, surgery

Causes in Alphabetical Order

The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3

References

  1. ↑ Fox, CS.; Parise, H.; D'Agostino, RB.; Lloyd-Jones, DM.; Vasan, RS.; Wang, TJ.; Levy, D.; Wolf, PA.; Benjamin, EJ. (2004). "Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring". JAMA. 291 (23): 2851–5. doi:10.1001/jama.291.23.2851. PMID 15199036. Unknown parameter |month= ignored (help)
  2. ↑ 2.0 2.1 Zimetbaum, PJ.; Josephson, ME.; McDonald, MJ.; McClennen, S.; Korley, V.; Ho, KK.; Papageorgiou, P.; Cohen, DJ. (2000). "Incidence and predictors of myocardial infarction among patients with atrial fibrillation". J Am Coll Cardiol. 36 (4): 1223–7. PMID 11028474. Unknown parameter |month= ignored (help)
  3. ↑ 3.0 3.1 Goldhaber, SZ.; Visani, L.; De Rosa, M. (1999). "Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)". Lancet. 353 (9162): 1386–9. PMID 10227218. Unknown parameter |month= ignored (help)
  4. ↑ 4.0 4.1 Krahn, AD.; Manfreda, J.; Tate, RB.; Mathewson, FA.; Cuddy, TE. (1995). "The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study". Am J Med. 98 (5): 476–84. doi:10.1016/S0002-9343(99)80348-9. PMID 7733127. Unknown parameter |month= ignored (help)
  5. ↑ 5.0 5.1 Kannel, WB.; Abbott, RD.; Savage, DD.; McNamara, PM. (1982). "Epidemiologic features of chronic atrial fibrillation: the Framingham study". N Engl J Med. 306 (17): 1018–22. doi:10.1056/NEJM198204293061703. PMID 7062992. Unknown parameter |month= ignored (help)
  6. ↑ 6.0 6.1 6.2 Grigioni, F.; Avierinos, JF.; Ling, LH.; Scott, CG.; Bailey, KR.; Tajik, AJ.; Frye, RL.; Enriquez-Sarano, M. (2002). "Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome". J Am Coll Cardiol. 40 (1): 84–92. PMID 12103260. Unknown parameter |month= ignored (help)
  7. ↑ Tikoff, G.; Schmidt, AM.; Hecht, HH. (1968). "Atrial fibrillation in atrial septal defect". Arch Intern Med. 121 (5): 402–5. PMID 5645716. Unknown parameter |month= ignored (help)
  8. ↑ Ridker PM, Gibson CM, Lopez R (1989). "Atrial fibrillation induced by breath spray". N Engl J Med. 320 (2): 124. PMID 2914028.
  9. ↑ Buch, P.; Friberg, J.; Scharling, H.; Lange, P.; Prescott, E. (2003). "Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study". Eur Respir J. 21 (6): 1012–6. PMID 12797497. Unknown parameter |month= ignored (help)
  10. ↑ Benjamin, EJ.; Levy, D.; Vaziri, SM.; D'Agostino, RB.; Belanger, AJ.; Wolf, PA. (1994). "Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study". JAMA. 271 (11): 840–4. PMID 8114238. Unknown parameter |month= ignored (help)
  11. ↑ Robinson, K.; Frenneaux, MP.; Stockins, B.; Karatasakis, G.; Poloniecki, JD.; McKenna, WJ. (1990). "Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study". J Am Coll Cardiol. 15 (6): 1279–85. PMID 2329232. Unknown parameter |month= ignored (help)
  12. ↑ Cecchi, F.; Olivotto, I.; Montereggi, A.; Santoro, G.; Dolara, A.; Maron, BJ. (1995). "Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population". J Am Coll Cardiol. 26 (6): 1529–36. doi:10.1016/0735-1097(95)00353-3. PMID 7594081. Unknown parameter |month= ignored (help)
  13. ↑ WALSH, JJ.; BURCH, GE.; BLACK, WC.; FERRANS, VJ.; HIBBS, RG. (1965). "IDIOPATHIC MYOCARDIOPATHY OF THE PUERPERIUM (POSTPARTAL HEART DISEASE)". Circulation. 32: 19–31. PMID 14314486. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Atrial_fibrillation_causes&oldid=1092125"